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Abstract There is a higher prevalence of ischemic heart
disease (IHD) in South African white than black women.
The objective of this study was to determine biochemical
explanations for this prevalence. The study group con-
tained 15 obese black women (OBW) and 14 obese white
women (OWW), all premenopausal, who were examined
after an overnight fast. Anthropometric measurements and
blood concentrations of glucose, non-esterified fatty acids
(NEFAs), catecholamines, plasminogen activator inhibitor-1,
C-peptide, proinsulin, lipograms, cortisol, growth hormone,
and post-heparin lipoprotein lipase activity were measured
during an oral glucose tolerance test (OGTT). Body compo-
sition was measured using bioelectrical impedance analysis,
and subcutaneous and visceral fat mass were assessed with
CT-scans. Visceral fat area was higher in OWW (139.7 
 

 
10.7 cm
 
2
 
) than in OBW (72.3 
 

 
 3.9 cm
 
2
 
) (
 
P
 
 
 

 
 0.01), as were
fasting and 3 h triglyceride concentrations (
 
P
 
 
 

 
 0.05 for
all). OWW also had higher NEFA levels than OBW at 3 and
4 h compared with OBW (
 
P
 
 
 

 
 0.05 for both). Fasting corti-
sol (266 
 

 
 24 vs. 197 
 

 
 19 nmol/l; 
 
P
 
 
 

 
 0.05) was higher in
OWW than in OBW.  These data demonstrate that OWW
have higher visceral fat mass than OBW, which may lead to
a more atherogenic fasting and postprandial lipid profile.
The higher cortisol levels of the OWW may promote vis-
ceral fat deposition.
 
—Punyadeera, C., M-T. van der Merwe,
N. J. Crowther, M. Toman, G. P. Schlaphoff, and I. P. Gray.
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Obesity (body mass index 
 

 
30 kg/m
 
2
 
), has a preva-
lence on the order of 59% in urban black women and
24% in urban white women between the ages of 45–54
years (1). Urban black women, who have a westernized
diet and lifestyle, present with more hypertension (30% vs.
15%) and a higher prevalence of type 2 diabetes (7% vs.
3.6%) than do white women (2–4), but have a lower mor-
tality due to ischemic heart disease (IHD) (5–7). The
 
most recent epidemiological study has shown that the in-
cidence of death from IHD within the female population
of South Africa is 8 per 100,000 for blacks and 55 per
100,000 for whites (7); however, it is not known if this is
also the case for the obese subgroups in each of these two
populations. Previous research has also demonstrated a
less atherogenic fasting lipid profile in the South African
black, as compared with the white, population (8).
The aim of the present investigation was, therefore, to
study the lipid profile of the prolonged post-glucose phase
and to measure biochemical and anthropometric vari-
ables that may contribute to the higher prevalence of IHD
in the white population. Plasminogen activator inhibitor-1
(PAI-1), visceral fat mass, and fasting and post-glucose li-
pograms were analyzed together with hormonal factors
that are known to affect lipid metabolism, i.e., insulin,
growth hormone, cortisol, adrenaline, and noradrenaline
during an oral glucose tolerance test (OGTT).
MATERIAL AND METHODS
 
Subjects
 
The study group consisted of 48 premenopausal South Afri-
can women residing in the greater Johannesburg area selected
according to various criteria, which included age, body mass
index (BMI), premenopausal status, socioeconomic back-
ground, and absence of any metabolic disorders. Of these 48, 29
were obese women (15 black and 14 white). The subjects were
defined as obese, i.e., BMI 
 

 
30, using the WHO criteria (9), and
were studied during the first 10 days of the follicular phase of
the menstrual cycle. All the subjects had normal liver and kidney
function and parity of fewer than 5, and were not on oral contra-
 
Abbreviations: PAI-1, plasminogen activator inhibitor; HSL, hor-
mone sensitive lipase; LPL, lipoprotein lipase; HDL, high density lipo-
protein; LDL, low density lipoprotein; OBW, obese black women;
OWW, obese white women.
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ceptives. The subjects with metabolic or endocrine disorders
were excluded from the study. Subjects were asked to refrain
from smoking and vigorous exercise for 48 h prior to the onset
of the study. None of the subjects were on any medication known
to affect lipid metabolism.
This study protocol was approved by the University of Witwa-
tersrand, Faculty of Health Sciences Human Ethics Committee,
and each subject gave written consent. Ten obese women (5
black and 5 white) were also enrolled in a study for the determi-
nation of lipoprotein lipase (LPL) activity, and were selected ac-
cording to the criteria discussed above.
 
Study protocol
 
After a 10–12- h overnight fast, the subjects were weighed and
their height measured. Lean mass (kg;%) and fat mass (kg;%)
were measured using a Bodystat 1500 bioelectrical impedance
analyser (The Bodystat Ltd., Douglas, UK) (10). The bioimped-
ance equations used were based on the South African popula-
tion as a whole [Fat free mass (kg) 
 

 
 aH
 
2
 
/z 
 

 
 bH
 
2
 
/wt 
 

 
 cH 
 

 
 d
age 
 

 
 e: H (height); wt (body mass); z (whole body impedance);
a, b, c, d, and e are regression coefficients, validated by the
Dunn Nutritional Centre, University of Cambridge, UK]. For ac-
curate results the subjects did not drink for 4 h prior to the test,
did not consume alcohol for 24 h prior to the test, nor partake
in vigorous exercise for 48 h prior to the test. Waist-to-hip ratio
(WHR) was measured by taking waist circumference as the mid-
point between the lower rib margin and the iliac crest, and hip
circumference as the widest circumference of the buttock.
 
CT scan measurements
 
A five-level CT scan was performed using computerized axial
tomography (CT scan, Philips SR 7000, Netherlands). The scan
parameters were 1) 10-mm slice thickness; 2) 120 kV; 3) 250 mA;
4) 2 s; and 5) 34–480-mm field of view, depending on the size of
the subject. Photographic images were taken in the resting expi-
ration. Subcutaneous adiposity was measured using a five-level
CT scan ranging from the diaphragm, umbilicus, L4-5 lumbar
disc, widest diameter of the pelvis, and mid-thigh (the total dis-
tance from the iliac crest to the acetabulum and from the acetab-
ulum to the knee joint, divided by 2). The first scanogram in-
cluded the diaphragm, the umbilicus (marked with a metal
coin), iliac crest, and symphysis pubis, with a maximal length of
500 mm from the umbilicus. The second scanogram extended
from the symphysis pubis to the knees. The widest parasagittal
diameter was measured at the level of L4-5. The fat areas were
calculated with a region of interest seeding program on a Philips
Gyroview workstation (fat values between 
 

 
30 and 
 

 
130 HU
were chosen). Subcutaneous and visceral fat areas were calculated
separately, and the anatomical boundaries were as described previ-
ously (11, 12). Abdominal visceral fat was measured at the top
three levels (10). The anthropometric measurements, clinical
characteristics and body composition measurements appear in
 
Table 1
 
.
 
OGTT
 
With the subject in the supine position, a polyethylene cathe-
ter was inserted intravenously into the forearm, which was cov-
ered in a heating blanket to ensure sampling of arterialized
venous blood (13). Normal saline (20 ml) was used to maintain
patency of the iv catheter. Blood samples were taken at time in-
tervals as documented in 
 
Table 2
 
, and in all subjects the fasting
sample was taken at 7:30 
 
am
 
 (
 

 
15 min). A standardized glucose
load of 75 g (SARCHEM, Johannesburg, South Africa) in 200 ml
of water was given to the subjects over a 2-min period. The blood
samples for catecholamines were placed on ice instantly and
were centrifuged within 10 min. All samples were centrifuged at
4
 

 
C, and the supernatants frozen and stored at
 

 
70
 

 
C until anal-
ysis as a single batch. A bolus of 5,000 units of heparin was in-
jected 3 h after the glucose load, and samples were collected into
heparinized tubes immediately before and 10 min after heparin
administration to determine LPL activity.
 
Biochemical methods
 
Plasma levels of glucose (normal range: fasting 3 –6 mmol/l)
were analyzed by a commercially available enzymatic colorimet-
ric method, GOD-PAP (Boehringer, Mannheim, Germany);
NEFA (normal range: fasting 100 –600 
 
	
 
mol/l) was assayed
using an enzymatic colorimetric method (Boehringer); glycerol
(normal range: fasting 32 –187 
 
	
 
mol/l) was analyzed by auto-
mating an existing Boehringer Mannheim food assay kit to run
on BM/Hitachi autoanalyser 917; catecholamines (normal
range: fasting adrenaline 560-2,636 pmol/l and fasting noradren-
aline 
 

 
366 pmol/l) were measured using a standard high per-
formance liquid chromatography technique (instruments and
chemicals; Chromsystems, Munich, Germany). Serum triglycer-
ide levels (normal value: fasting 
 

 
2 mmol/l), total cholesterol
(normal value: fasting 
 

 
5.2 mmol/l), and high density lipopro-
tein (HDL) (normal levels for women: fasting 
 

 
0.9 mmol/l)
were measured using enzymatic assay kits (Boehringer). The low
density lipoprotein (LDL) levels were calculated (14) at fasting
TABLE 1. Anthropometric data for the four groups of women
 
Variables Obese White (n 
 

 
 14) Obese Black (n 
 

 
 15)
 
Age (years) 42.8 
 

 
 2.5 (40.5) 45.5 
 

 
 2.2 (44)
Weight (kg) 99.5 
 

 
 3.1 (95.9)
 
a
 
92.5 
 

 
 2.6 (93.6)
BMI (kg/m
 
2
 
) 38.5 
 

 
 1.2 (38.6) 36.8 
 

 
 1.1 (37.0)
Waist circumference (cm) 101.5 
 

 
 2.9 (103)
 
b
 
94.8 
 

 
 2.7 (95)
Hip circumference (cm) 123.7 
 

 
 2.6 (121.0) 123.5 
 

 
 2.1 (123.7)
WHR 0.83 
 

 
 0.01 (0.84)
 
b
 
0.77 
 

 
 0.02 (0.77)
Fat (kg) 50.7 
 

 
 2.4 (51.7)
 
a
 
45.8 
 

 
 2.4 (52.8)
Percentage fat (%) 50.3 
 

 
 1.2 (51.1) 50.1 
 

 
 1.7 (46.1)
Lean (kg) 49.6 
 

 
 1.2 (48.9) 45.8 
 

 
 1.3 (45.3)
Percentage lean (%) 49.6 
 

 
 1.3 (48.9) 49.8 
 

 
 1.7 (47.2)
Subcutaneous fat (cm
 
2
 
)
 
c
 
549.0 
 

 
 42.6 (475.7) 512.4 
 

 
 32.0 (499.5)
Visceral fat (cm
 
2
 
)
 
c
 
139.7 
 

 
 10.7 (128.1)
 
b
 
72.3 
 

 
 3.9 (70.6)
Mean values 
 

 
 SEM; median values are given in parentheses. BMI, body mass index; WHR, waist-to-hip ratio.
 
a
 
P
 
 
 

 
 0.05 OWW versus OBW; 
 
b
 
P
 
 
 

 
 0.01 OWW versus OBW.
 
c
 
Fat area measured in 9 OWW and 10 OBW.
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and at 3 and 4 h postprandially. Insulin (normal range: fasting
10–73 pmol/l) concentrations in the serum were determined by
an enzyme-amplified immunoassay (Mercodia, Upsala, Sweden).
C-peptide concentrations (normal range: fasting 0.3 –1.32
nmol/l) were determined by chemiluminescent enzyme immu-
noassay (Chiron Diagnostics, Emeryville, CA). The lower limit of
detection for the C-peptide assay was 0.99 nmol/l. Proinsulin
(normal range: fasting 1.30 –2.78 pmol/l) was measured using a
two-site immunoradiometric assay (15). The lower limit of detec-
tion for proinsulin was 1 pmol/l. A commercially available assay
kit (ACS: 180; Chiron diagnostics, Boston, MA) was used to
measure the cortisol levels (normal range: fasting 200 –650
nmol/l) in serum samples and growth hormone (normal range:
1–10 mIU/l) was measured by enzyme immunometric assay
using an IMMULITE assay kit (Diagnostic Product Corpora-
tion, Los Angeles, CA). For determining LPL activity (normal
range: 53–361 ng/ml), a MARKIT-F-LPL kit (Dainippon Pharma-
ceutical Co. Ltd., Oska, Japan) was used. PAI-1 (normal value:
45 
 

 
 33 ng/ml) concentrations in the fasted samples were
measured using a COALIZA method (Chromogenix, Amster-
dam, Netherlands). The intra- and interassay coefficients of
variation (CV) for the assays were as follows: glucose 0.9% and
1.8%; NEFA 
 

 
5% for both; glycerol 2.5% and 2.59%; adrena-
line 5.0% and 5.7%; noradrenaline 4.5% and 3.9%; LPL 
 

 
5%
for both; plasminogen activator inhibitor-1 5.5% and 7.3%; tri-
glycerides 1.5% and 1.8%; total cholesterol 0.8% and 1.7%;
HDL 1.3% and 2.6%; insulin 4% and 3.6%; C-peptide 6.3% and
5.3%; proinsulin 
 

 
5% for both; cortisol 4.5% and 6.4%; and
growth hormone 6.2% and 5.7%, respectively.
 
Statistical analysis
 
Data in the text, figures, and tables are presented as means 
 

 
SEM, and statistical analysis was carried out using Statistica
V5.0 (Statsoft Inc., 1984 –1996). One-way analysis of covari-
ance (ANCOVA) was used to measure the differences between
the means of biochemical variables (
 
Figs. 1–3
 
) for the two
obese study groups, adjusting for weight and waist circumfer-
ence (where appropriate). One-way ANCOVA was also used
for the comparison of anthropometric means adjusting for to-
tal body fat when analyzing visceral and subcutaneous adipose
areas. Partial correlation analyses were used to test whether
correlation existed in either of the subgroups and in the full
combined group. Differences in correlations between groups
were examined using multiple regression analysis, with weight
included as a covariate. The appropriate slope and intercept
terms of the regression models were compared between the
groups, and a significance level of 
 
P
 
 
 

 
 0.05 was used in all sta-
tistical analyses. Cortisol and growth hormone data were non-
symmetrically distributed and were therefore log-transformed
for regression analysis. Total glucose, insulin, cortisol, growth
hormone, and NEFA during the 3-h OGTT were calculated by
measuring area under the curve (AUC) using the trapezoid
rule (16).
The number of subjects in each study group was sufficient to
detect statistically and clinically significant differences in the
metabolic variables under investigation.
 
RESULTS
 
Anthropometric measurements
 
Age, BMI, waist circumference, hip circumference,
body fat (%), lean body mass (kg), and amount of sub-
cutaneous abdominal fat were similar in both obese sub-
ject groups (see Table 1). The amount of visceral fat
mass and WHR were significantly higher in OWW than
in OBW (
 
P
 
 
 

 
 0.01).
 
Glucose concentrations
 
The mean (
 

 
 SEM) fasting and postprandial glucose
levels are shown in Fig. 1A. No differences were noted be-
tween the two groups. The total glucose level (AUC
 
0–180min
 
;
expressed in mol/l 
 


 
 min) in OBW (1.24 
 

 
 0.03) was not
different from that in OWW (1.33 
 

 
 0.06).
 
Insulin concentrations
 
Obese black and white women had similar insulin lev-
els throughout the entire study (Fig. 1B). No differ-
ences in total insulin (AUC
 
0 – 180min
 
) were documented
between OBW (84.8 
 

 
 12.0) and OWW (88.2 
 

 
 12.0
nmol/l 
 


 
 min).
 
C-peptide concentrations
 
The 60-min C-peptide level was higher in OWW than in
OBW (Fig. 1C), and total C-peptide (AUC
 
0–180min
 
) (555 
 

 
43 vs. 443 
 

 
 39 nmol/l 
 min; P  0.05) was also higher in
OWW than in OBW.
TABLE 2. Study design
Time (min)
Analytes 0 30 60 120 180 240
Glucose Yes Yes Yes Yes Yes —
Insulin Yes Yes Yes Yes Yes —
Proinsulin Yes Yes Yes Yes Yes —
C-peptide Yes Yes Yes Yes Yes —
Cortisol Yes Yes Yes Yes Yes —
Growth hormone Yes Yes Yes Yes Yes —
Lipogram Yes — — — Yes Yesa
PAI-1 Yes — — — — —
LPL — — — — Yes —
Adrenaline Yes — — — Yes —
Noradrenaline Yes — — — Yes —
NEFA Yes Yes Yes Yes Yes Yesa
Yes, blood was collected and assayed at that time point; —, no blood collected; NEFA, non-esterified fatty acid.
a Plasma samples were collected from 9 OWW and 10 OBW.
 at Univ of Queensland (CAUL), on September 23, 2015
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Serum proinsulin concentrations
No interethnic differences were noted in total (3.20 
0.40 for OWW and 2.70  0.40 nmol/l 
 min for OBW)
or fasting (Fig. 1D) proinsulin levels between the two
groups.
Fasting and post-glucose lipid profile
The OWW had significantly higher fasting total choles-
terol, triglyceride, and LDL than did OBW (P  0.05 for
all) (Table 3). Triglyceride at 3 h (1.51  0.19 mmol/l vs.
0.83  0.13 mmol/l) (P  0.01) and at 4 h (1.73  0.27 vs.
0.89  0.18 mmol/l) (P  0.01) were higher in OWW
than in OBW (Table 3). The 3- and 4-h triglyceride levels
correlated positively with visceral fat mass independent of
age and weight in obese women (r  0.54, n  19, P  0.05).
Cortisol, catecholamine, and growth 
hormone concentrations
Fasting cortisol levels were higher in OWW (266  24
nmol/l) than in OBW (197  19 nmol/l; P  0.05) (Fig.
2A), but total AUC levels were not different (43.5  5.9
for OWW and 34.7  2.7 mmol/l 
 min for OBW).
No differences were noted in growth hormone levels
(Fig. 2B), and total AUC levels were also similar (315  69
for OWW and 200  56 mIU/l 
 min for OBW).
Adrenaline levels at fasting were 222.2  72.7 and 128.0 
41.0 pmol/l, and at 3 h were 247.0  89.7 and 225.0  69.0
pmol/l in OWW and OBW, respectively. Noradrenaline
levels at fasting were 1,222  215 and 1,398  205 pmol/l,
and at 3 h were 1,354  143 and 2,039  757 pmol/l in
OWW and OBW, respectively. No significant differences
in levels of either catecholamine were noted.
Fig. 1. Plasma levels of glucose (A) and serum
levels of insulin (B), C-peptide (C), and proinsu-
lin (D) in  obese black and  obese white
women; §P  0.05 for obese black versus obese
white women.
Plasma NEFA concentrations
OWW had higher NEFA at 180 min (99.2  38.9 vs.
21.1  4.8 	mol/l, P  0.05) and 240 min (556.7  71.8
vs. 278.6  65.3 	mol/l, P  0.05) than did OBW (Fig. 3).
Total AUC NEFA levels were similar (59.7  8.1 in OWW
and 45.7  3.9 mmol/l 
 min in OBW). Percentage sup-
pression of NEFAs at 30 min of the OGTT from the fasting
value was 28.4  9.5% in OWW and --13.5  18.1% in
OBW (P  0.05), i.e., there was no suppression in the
early post-glucose NEFA levels in the latter group. Total
NEFA (AUC0–240min) correlated positively with visceral,
but not subcutaneous, fat mass, independent of age in the
obese women (r  0.52, P  0.05, n  18).
PAI-1 concentrations
Basal PAI-1 concentrations were as follows: OWW,
50.4  6.0 ng/ml and OBW, 45.2  6.2 ng/ml. No inter-
ethnic differences in the levels of PAI-1 were noted.
LPL concentrations
LPL activity was determined at the 240-min time point
of an OGTT and 10 min after injecting a bolus of heparin
in 5 OBW and 5 OWW. The results were as follows: OWW,
69.5  32.6 ng/ml and OBW, 39.7  9.6 ng/ml (P  ns).
DISCUSSION
Previous studies in South Africa have shown that is-
chemic heart disease (IHD) is far more prevalent in white
than in black women (5–7), despite a high incidence of
obesity in both populations (1). The present study was
 at Univ of Queensland (CAUL), on September 23, 2015
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undertaken to determine possible factors that may protect
the black population against IHD, despite the escalating
incidence of type 2 diabetes in South Africa (3, 4). Studies
have shown that the black population of South Africa has a
less atherogenic fasting lipid profile than the white popula-
tion (8, 17), and the present investigation confirmed this.
The present study shows that visceral fat area and WHR
were greater in the obese white population. This was not
simply a result of the greater fat mass of the OWW, as a sig-
nificant interethnic difference was still observed in an
ANCOVA correcting for fat mass. Previous studies of
OWW and OBW matched for fat mass also demonstrated
interethnic differences in visceral fat area (10, 18). This
fat depot is more lipolytically active than subcutaneous fat
(19, 20) owing to higher -adrenoreceptor-mediated
catecholamine-induced lipolysis and greater resistance to
the antilipolytic activity of insulin (21). The greater vis-
ceral fat mass may contribute to the poor lipid profile in
OWW via the release of NEFAs directly into the portal
vein (22). High NEFA levels in the liver increase hepatic
very low density lipoprotein output, leading to an increase
in plasma triglyceride and cholesterol concentrations
(23). High triglycerides in turn cause the production of
smaller LDL particles (24) and decrease HDL levels (25,
26). The present study demonstrates a positive correlation
between visceral fat mass and post-glucose triglyceride lev-
els. Furthermore, visceral fat mass (19) and C-peptide
concentrations (27) have both been positively associated
with an increased risk of IHD, and both these factors are
higher in OWW than in OBW. However, no interethnic
differences in PAI-1 concentrations were observed, and
therefore ethnic differences in the prevalence of IHD are
unlikely to be related to this peptide.
The NEFA levels during the late post-glucose period
were higher in OWW than in OBW. This was not due to
catecholamine or growth hormone levels, as these were
the same in both populations, confirming a previous study
(10). Visceral fat area was greater in OWW than in OBW
and it has been shown that in men with a higher visceral
fat mass than weight-matched controls, postprandial
NEFA levels were higher (28). The present study also
showed that NEFA levels correlated with visceral, but not
subcutaneous, fat area. The mechanism by which visceral
fat, which represents only a small percentage of the total
body fat mass (19), may cause high postprandial NEFA
concentrations in the general circulation is unclear, al-
though it has been suggested that high visceral fat mass
may impair the inhibition of adipose tissue lipolysis (29).
The subcutaneous adipose tissue depot may also be in-
volved in the exaggerated post-glucose NEFA response of
the OWW. A recent study has shown that OWW have
lower subcutaneous adipose tissue blood flow than do
OBW (10). Plasma NEFA uptake by adipose tissue may
thus be slower in OWW, and this may also contribute to
the elevated late post-glucose NEFA levels.
Fasting cortisol levels were found to be higher in OWW
than in OBW. This is unlikely to be due to differences in
sampling times, as the fasting blood samples were taken at
Fig. 2. Serum levels of cortisol (A) and growth hormone (B) in 
obese black and  obese white women; §P  0.05 for obese black
versus obese white women.
Fig. 3. Plasma levels of free fatty acids in  obese black and  obese
white women; §P  0.05 for obese black versus obese white women.
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the same time in all the subjects. Whether the circadian
rhythm of cortisol secretion (30) displays ethnic variation
is not known and should be investigated further. Cortisol
increases the levels of serum NEFA and LPL activity (31),
an enzyme crucial in the uptake of triglycerides by adipo-
cytes. Cortisol increases lipolysis via effects on gene tran-
scription with a recognized time lag (over 2–4 hours) be-
tween administration or secretion and response (32, 33).
The high NEFA levels in OWW at 3 and 4 h after oral ad-
ministration of the glucose load may, therefore, relate to
the high fasting cortisol.
The high cortisol levels in OWW may also explain the
high visceral fat mass in the former group (34, 35). Vis-
ceral fat is known to have a higher level of expression of
glucocorticoid receptors than other fat depots (36), and
this could lead to increased cortisol-associated metabolic
activity. Cortisol increases adipocyte LPL levels (37) and
reduces adipocyte hormone sensitive lipase (HSL) activity
(38) which could potentially lead to preferential deposi-
tion and maintenance of triglyceride stores in this adipose
depot. In addition, cortisol promotes adipogenesis (39),
and abdominal adipose stromal cells are more responsive
to this effect of cortisol than stromal cells from the femo-
ral adipose site (40). Furthermore, visceral adipose stro-
mal cells express higher levels of the cortisol-inducable
11-hydroxysteroid dehydrogenase type I isoenzyme (which
converts cortisone to cortisol) than subcutaneous adipo-
cytes (41). Therefore, the higher serum levels of cortisol
in OWW than in OBW may, in turn, enhance visceral fat
production of this hormone in OWW. The reason for the
higher serum cortisol levels in the white women is not
known and obviously warrants further investigation, in-
cluding measurement of hypothalamic-pituitary-adrenal
axis activity.
The suppression of NEFA levels 30 min after adminis-
tration of an oral glucose load was much greater in OWW
than in OBW, and may be due to reduced insulin sensitiv-
ity of adipocytes from OBW. Both in vivo (10) and in vitro
studies (42) have shown that adipocytes of OBW were
more resistant to the antilipolytic action of insulin than
those from OWW. This is mirrored by greater whole-body
insulin resistance in OBW than in OWW (43), despite the
higher level of visceral fat in the latter group, an observa-
tion that has also been made about Africans compared
with European-Americans (44). This contradictory data
may be explained by ethnic differences in adipocyte me-
tabolism (10, 42), which is further emphasized by the
finding that leptin levels are higher in OBW than in
OWW (18).
It has been hypothesized that the poorer glucose toler-
ance observed in obese black South Africans may relate to
lower pancreatic -cell numbers (45). It has been sug-
gested that poor fetal growth, possibly as a result of fetal
malnutrition, may lead to reduced -cell numbers and in-
creased insulin resistance (46). A recent study has shown
that there is a correlation between glucose tolerance and
birth weight within an urban population of black South
African children (47), and it has also been shown that the
insulin sensitivity of adipocytes can be affected by nutri-
tion during fetal and neonatal life (48). Therefore, it is
possible that poor nutrition during these periods of life
may cause changes in both peripheral and whole-body in-
sulin sensitivity in this human population.
Although the number of subjects studied in this investi-
gation was small, we believe that our conclusions are
valid. The data are supported by results from other
studies showing that visceral fat levels are lower in black
than in white obese subjects (44, 49) and that lipid pro-
files are less atherogenic in the former population (8,
50, 51). Furthermore, the higher fasting cortisol and late
post-glucose NEFA levels in OWW than in OBW have been
confirmed in white and black obese diabetic women (C.
Punyadeera et al., unpublished observations).
In summary, the present study has, for the first time in
South Africa, examined lipid profiles and related factors
during the early and late post-glucose phases. OWW have
an adverse lipid profile compared with OBW, and this
may be associated with higher visceral fat mass. The
more atherogenic lipid profiles of OWW than of OBW
are in keeping with data from studies in Africa (8, 17)
and America (50, 51). It further appears that the high
late post-glucose NEFA concentrations in the OWW
could also be due to greater visceral fat mass, decreased
subcutaneous adipose tissue blood flow (10), or both.
Furthermore, the higher cortisol levels in the white fe-
males may promote visceral fat deposition and increase
LPL levels. Therefore, multiple factors appear to offer
black women from South Africa protection against IHD,
despite their higher degree of muscle and adipose tissue
insulin resistance.
This research was funded by the South African Institute for
Medical Research (SAIMR), the South African Sugar Associa-
tion, the University of the Witwatersrand Research Commit-
tee, Professor John Kalk, Servier and Roche Pharmaceuticals.
We thank Sisters Nomsa Ramela and Nancy Holden for carry-
TABLE 3. Fasting and postprandial lipogram results for
the four groups of women
Analytes
(mmol/l)
Obese White
(n  14)
Obese Black
(n  15)
Fasting
Total cholesterol 5.76  0.35 4.40  0.19a
Triglyceride 1.70  0.22 0.96  0.12a
HDL-C 1.45  0.20 1.43  0.11
LDL-C 3.55  0.28 2.53  0.21a
3 hours
Total cholesterol 5.11  0.32 3.89  0.26
Triglyceride 1.51 0.19 0.83  0.13b
HDL-C 0.95  0.08 0.91  0.08
LDL-C 3.47  0.28 2.61  0.20
4 hoursc
Total cholesterol 4.79  0.40 4.22  0.26
Triglyceride 1.73  0.27 0.89  0.18b
HDL-C 0.84  0.06 1.00  0.09
LDL-C 3.14  0.36 2.82  0.24
a P  0.05 OBW versus OWW; 
b P  0.01 OBW versus OWW.
c Blood samples collected from 9 OWW and 10 OBW.
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